about
Current immunological and molecular tools for leptospirosis: diagnostics, vaccine design, and biomarkers for predicting severityDiscovery of Novel Leptospirosis Vaccine Candidates Using Reverse and Structural Vaccinology.Xanthan gum as an adjuvant in a subunit vaccine preparation against leptospirosis.Human leptospirosis: seroreactivity and genetic susceptibility in the population of São Miguel Island (Azores, Portugal)Identification of immunodominant antigens in canine leptospirosis by Multi-Antigen Print ImmunoAssay (MAPIA)Evaluation of the Leptospira interrogans Outer Membrane Protein OmpL37 as a Vaccine CandidateUsing discrete choice modeling to evaluate the preferences and willingness to pay for leptospirosis vaccineProtection against lethal leptospirosis after vaccination with LipL32 coupled or coadministered with the B subunit of Escherichia coli heat-labile enterotoxinLigB subunit vaccine confers sterile immunity against challenge in the hamster model of leptospirosis.DNA prime-protein boost based vaccination with a conserved region of leptospiral immunoglobulin-like A and B proteins enhances protection against leptospirosisInfection with Leptospira kirschneri Serovar Mozdok: First Report from the Southern Hemisphere.A conserved region of leptospiral immunoglobulin-like A and B proteins as a DNA vaccine elicits a prophylactic immune response against leptospirosis.A prime-boost strategy using the novel vaccine candidate, LemA, protects hamsters against leptospirosis.Characterization of a virulent Leptospira interrogans strain isolated from an abandoned swimming poolImmune response in hamsters immunised with a recombinant fragment of LigA from Leptospira interrogans, associated with carrier molecules.Reverse Vaccinology: An Approach for Identifying Leptospiral Vaccine Candidates.A Universal Vaccine against Leptospirosis: Are We Going in the Right Direction?Protective Immunity and Reduced Renal Colonization Induced by Vaccines Containing Recombinant Leptospira interrogans Outer Membrane Proteins and Flagellin Adjuvant.Human leptospirosis vaccines in China.Heterologous expression and purification of Leptospira spp recombinant proteins to leptospirosis vaccine development.Mannosylated LigANI produced in Pichia pastoris protects hamsters against leptospirosis.Cytokine expression profile in hamsters immunized with OmpL37 from Leptospirainterrogans in different vaccine formulations.Advances & challenges in leptospiral vaccine development.Heterologous DNA prime-protein boost immunization with RecA and FliD offers cross-clade protection against leptospiral infection.Evaluation of Lsa46 and Lsa77 Leptospiral Proteins for Their Immunoprotective Activities in Hamster Model of Leptospirosis.
P2860
Q26863215-646A650F-2DE6-4292-902E-9BB69C28F61EQ30061569-0F0B3423-A264-40EA-88DB-C41BB8640D64Q33661011-26068550-CA29-4802-BB75-7D4FCCBCD25CQ34257487-F996E285-C8E8-4612-92D6-2DDF32BC6AA3Q34721822-2A7FF386-BF4E-4BA8-B833-61FE504390C1Q35847270-DEBA2EF1-B527-440A-A832-100B06E53FD1Q35887386-A0107967-BAFA-49FE-87CF-F302419C9134Q35940659-976A3DAD-1D26-4BC2-A3A9-E0F416E8B134Q36310414-C67D74DF-9130-4F30-8003-93C948AB4399Q36450316-FE8FA0D3-9383-4C56-AA67-A6E6D336313FQ36644409-C7313464-EEE5-4372-A088-CC8248BB1AD5Q36826324-9125494F-8E47-4A37-8B43-783E38D355F2Q36826369-4EB0DC97-A9F4-47B2-A87C-D71FBC474659Q37244534-642BA407-6A50-4848-9C85-0F30F79514E2Q37444514-9E481895-C532-451F-82F5-1BC196D4BD82Q37631622-DDF74E22-37FD-4B33-9391-C22CE0E07652Q37690431-0648C83C-5BF2-4B7C-B789-461A4612760CQ41822782-8701B598-8272-4D89-BC5F-5BAE7D08F1C6Q43366479-03C91EDD-9E91-4317-974C-5993AB905ED0Q50280894-6600DD26-1242-472B-9C4A-72C1EC97F136Q51750815-C0D3C637-E3DB-4111-A579-1DF88E8B1BC7Q55221907-7CBBAC49-5A6B-45D2-8FAE-2ABFDF038635Q55227889-6DB63D74-CF6D-4F20-8864-2B30CCC25534Q55293180-5BAD8A1E-2098-4F7D-B4FA-F712499B5727Q55485018-7A9FB11A-D705-4844-B856-8C0A8ABA7A82
P2860
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Recombinant vaccines against leptospirosis.
@en
type
label
Recombinant vaccines against leptospirosis.
@en
prefLabel
Recombinant vaccines against leptospirosis.
@en
P2093
P2860
P356
P1433
P1476
Recombinant vaccines against leptospirosis
@en
P2093
André A Grassmann
Daiane D Hartwig
Samuel R Félix
Éverton F da Silva
P2860
P304
P356
10.4161/HV.7.11.17944
P577
2011-11-01T00:00:00Z